FDA discussion paper: competency-style testing for genAI medical devices; comments through 19 Oct 2026.

Quoted text

FDA floats doctor-style “competency” testing for GenAI medical devices in a new discussion paper on risk, premarket eval & postmarket monitoring. Comment period open until October 19 as US aims to set the global model/standard. https://www.fda.gov/news-events/press-announcements/fda-seeks-public-feedback-inform-regulatory-approach-generative-ai-enabled-medical-devices

Read and engage with the original on X. This desk is not a republication feed.

Analyst rationale

Primary regulator process, not an incident. Mitigation-progress on the clinical card. Residual is unchanged until a rule ships.